Growth Metrics

Enovis (ENOV) Income from Continuing Operations (2010 - 2026)

Enovis (ENOV) reported Income from Continuing Operations of 8411000.0 for Q2 2026, up 84.87% year-over-year from 4549760.87 in Q2 2025, and up 98.38% on a QoQ basis from 518803000.0 in Q4 2025.

Enovis (ENOV) has 17 years of Income from Continuing Operations data on file, last reported at 8411000.0 in Q2 2026.

  • Quarterly Income from Continuing Operations rose 84.87% year-over-year to 8411000.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was 1134542000.0 (down 39.87% YoY) and the FY2025 annual result came in at 1181711000.0, down 42.82% from the prior year.
  • Income from Continuing Operations rose to 8411000.0 in Q2 2026 per ENOV's latest filing, from 518803000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 120600000.0 in Q3 2022 and bottomed at 703626000.0 in Q4 2024.
  • The 5-year median for Income from Continuing Operations is 36455000.0 (2025), against an average of 124097470.59.
  • The widest annual swing landed in 2022, when Income from Continuing Operations surged 386.39%; it then sank 23034.35% in 2024.
  • Tracing ENOV's Income from Continuing Operations over 5 years: stood at 54840000.0 in 2022, then soared by 105.59% to 3068000.0 in 2023, then slumped by 23034.35% to 703626000.0 in 2024, then advanced by 26.27% to 518803000.0 in 2025, then surged by 98.38% to 8411000.0 in 2026.
  • Per Business Quant, the three latest ENOV Income from Continuing Operations figures stand at 8411000.0 (Q2 2026), 518803000.0 (Q4 2025), and 570873000.0 (Q4 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 1.08 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 745.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 1.15 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 380.70 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 273.95 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 199.50 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 411.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 220.30 Mn
10 Enovis 1.25 Bn 1.22 Bn 365.49 Mn -8.41 Mn

Historic Data

Download Data 🔒
DateValue
Apr 3, 2026 -8.41 Mn
Dec 31, 2025 -518.80 Mn
Oct 3, 2025 -570.87 Mn
Jul 4, 2025 -36.46 Mn
Apr 4, 2025 -55.58 Mn
Dec 31, 2024 -703.63 Mn
Sep 27, 2024 -33.51 Mn
Jun 28, 2024 -18.44 Mn
Mar 29, 2024 -71.84 Mn
Dec 31, 2023 3.07 Mn
Sep 29, 2023 -19.45 Mn
Jun 30, 2023 -14.61 Mn
Mar 31, 2023 -22.85 Mn
Dec 31, 2022 -54.84 Mn
Sep 30, 2022 -65.95 Mn
Jul 1, 2022 120.60 Mn
Apr 1, 2022 -38.09 Mn
Dec 31, 2021 -14.75 Mn
Oct 1, 2021 -13.58 Mn
Jul 2, 2021 -42.11 Mn
Apr 2, 2021 27.75 Mn
Dec 31, 2020 -97.03 Mn
Oct 2, 2020 16.84 Mn
Jul 3, 2020 -3.14 Mn
Apr 3, 2020 8.87 Mn
Dec 31, 2019 34.41 Mn
Sep 27, 2019 3.80 Mn
Jun 28, 2019 2.25 Mn
Mar 29, 2019 -21.50 Mn
Dec 31, 2018 36.61 Mn
Sep 28, 2018 16.61 Mn
Jun 29, 2018 47.90 Mn
Mar 30, 2018 31.88 Mn
Dec 31, 2017 -83.80 Mn
Sep 29, 2017 49.62 Mn
Jun 30, 2017 41.86 Mn
Mar 31, 2017 38.39 Mn
Dec 31, 2016 43.17 Mn
Sep 30, 2016 40.55 Mn
Jul 1, 2016 43.96 Mn
Apr 1, 2016 26.21 Mn
Dec 31, 2015 -2.87 Mn
Sep 25, 2015 23.55 Mn
Jun 26, 2015 58.83 Mn
Mar 27, 2015 56.28 Mn
Dec 31, 2014 85.79 Mn
Sep 26, 2014 81.30 Mn
Jun 27, 2014 198.34 Mn
Mar 28, 2014 54.84 Mn
Dec 31, 2013 44.19 Mn
Sep 27, 2013 65.48 Mn
Jun 28, 2013 67.20 Mn
Mar 29, 2013 32.28 Mn
Dec 31, 2012 25.07 Mn
Sep 28, 2012 14.50 Mn
Jun 29, 2012 18.63 Mn
Mar 30, 2012 -100.46 Mn
Dec 31, 2011 -16.08 Mn
Sep 30, 2011 3.69 Mn
Jul 1, 2011 10.39 Mn
Apr 1, 2011 6.56 Mn
Dec 31, 2010 8.65 Mn
Oct 1, 2010 5.85 Mn
Jul 2, 2010 2.09 Mn